MM Mobile
Detailed App Info:
Application Description
Managing Myeloma (MM) is pleased to announce the launch of MM Mobile, a brand new FREE application to stay current with the latest information and educational programs in the management of multiple myeloma. Included is a valuable collection of current news, clinical support resources and easy-to-use calculators for ISS staging and creatinine clearance designed for health care professionals, including physicians, nurses, pharmacists, physician assistants, students, and more.
MM Mobile Features
MM News Updates
Continually updated news feed offering succinct information on therapeutic trials, guideline updates, and industry information.
MM FAQs
Leading experts provide concise answers to frequently asked questions about treatment, side effects of therapeutic agents, and best practices.
Myeloma Treatment Resource Calculators
Quick, easy-to-use ISS staging and creatinine clearance calculators provide practice support. The ISS staging calculator includes historic survival data by stage. The creatinine clearance calculator offers dose adjustments for lenalidomide and zoledronic acid based on the calculated CLcr.
All resources on MM Mobile are continually updated, providing highly useful information in a convenient, fast, and easy-to-use application right at your fingertips. More helpful tools are available at ManagingMyeloma.com under the Tools tab/Myeloma Treatment Resource.
Why should I download the MM Mobile app?
FREE – no cost to download enabling access to an array of multi award-winning, robust multimedia resources
FAST – access a highly useful collection of information and clinical support resources right at your fingertips
CONVENIENT – three different and convenient media formats are available to suit your personal preferences including TEXT, AUDIO and VIDEO. Continual and complimentary HELP support is available
LANGUAGES:
English
REQUIREMENTS:
Compatible with iPhone and iPod Touch
Requires iPhone/iPod iOS4.0 or later or iPad iOS3.2 or later.
mmmobile@managingmyeloma.com
MM Mobile Features
MM News Updates
Continually updated news feed offering succinct information on therapeutic trials, guideline updates, and industry information.
MM FAQs
Leading experts provide concise answers to frequently asked questions about treatment, side effects of therapeutic agents, and best practices.
Myeloma Treatment Resource Calculators
Quick, easy-to-use ISS staging and creatinine clearance calculators provide practice support. The ISS staging calculator includes historic survival data by stage. The creatinine clearance calculator offers dose adjustments for lenalidomide and zoledronic acid based on the calculated CLcr.
All resources on MM Mobile are continually updated, providing highly useful information in a convenient, fast, and easy-to-use application right at your fingertips. More helpful tools are available at ManagingMyeloma.com under the Tools tab/Myeloma Treatment Resource.
Why should I download the MM Mobile app?
FREE – no cost to download enabling access to an array of multi award-winning, robust multimedia resources
FAST – access a highly useful collection of information and clinical support resources right at your fingertips
CONVENIENT – three different and convenient media formats are available to suit your personal preferences including TEXT, AUDIO and VIDEO. Continual and complimentary HELP support is available
LANGUAGES:
English
REQUIREMENTS:
Compatible with iPhone and iPod Touch
Requires iPhone/iPod iOS4.0 or later or iPad iOS3.2 or later.
mmmobile@managingmyeloma.com
Requirements
Your mobile device must have at least 2.37 MB of space to download and install MM Mobile app. MM Mobile was updated to a new version. Purchase this version for $0.00
If you have any problems with installation or in-app purchase, found bugs, questions, comments about this application, you can visit the official website of MediCom Worldwide, Inc. Corona Productions, Inc. at http://www.managingmyeloma.com/index.php?option=com_content&view=article&id=504&Itemid=58.
Copyright © MediCom Worldwide, Inc.
